gallopamil has been researched along with Coronary Disease in 50 studies
Gallopamil: Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomised, crossover trial, 20 patients with electrocardiographically proven coronary heart disease and exercise-inducible angina pectoris, the antiischemic effect of gallopamil (3 x 50 mg) and molsidomine (2 x 2 mg) were studied." | 9.06 | [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study]. ( Zebe, H, 1989) |
| "We studied the effects of slow-release gallopamil two-times 100 mg on exercise-induced ST-segment depression, as well as on the incidence of spontaneous myocardial ischemia detected by long-term ECG monitoring for 48 h in patients with coronary artery disease and stable angina pectoris." | 9.06 | [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study]. ( Reuschel-Janetschek, E; Steinbeck, C; von Arnim, T, 1989) |
| "Efficacy and tolerance of gallopamil (Procorum) were investigated over a period of 1 year under practice conditions in a total of 455 patients (254 male, 201 female), aged 62 years (male) and 66 (female) on an average, with electrocardiographically confirmed coronary heart disease." | 7.67 | [Multicenter long-term study of gallopamil in patients with coronary heart disease]. ( Schiemann, J; Sućić, M, 1984) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 7.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "In intact rats, as well as in isolated perfused rat hearts, the calcium antagonist gallopamil reduced the severity of ischemic and reperfusion-induced arrhythmias." | 7.67 | The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion. ( Bernauer, W, 1987) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 6.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)." | 5.26 | Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979) |
| "In a randomised, crossover trial, 20 patients with electrocardiographically proven coronary heart disease and exercise-inducible angina pectoris, the antiischemic effect of gallopamil (3 x 50 mg) and molsidomine (2 x 2 mg) were studied." | 5.06 | [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study]. ( Zebe, H, 1989) |
| "In 18 patients (17 male and 1 female, 40 to 63 years old) with coronary heart disease, a randomized double-blind study was carried out to investigate in comparison to placebo, the antiischemic effects of 5, 10 and 20 mg isosorbide dinitrate (ISDN) alone and in combination with gallopamil (G: 25 and 50 mg) or 80 mg propranolol (P: 80 mg) on the ischemic ST-segment-depression in standardized exercise ECGs." | 5.06 | [The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol]. ( Hopf, R; Kaltenbach, M; Sthler-Klich, HM, 1989) |
| "We studied the effects of slow-release gallopamil two-times 100 mg on exercise-induced ST-segment depression, as well as on the incidence of spontaneous myocardial ischemia detected by long-term ECG monitoring for 48 h in patients with coronary artery disease and stable angina pectoris." | 5.06 | [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study]. ( Reuschel-Janetschek, E; Steinbeck, C; von Arnim, T, 1989) |
| ", gallopamil retard represents a suitable medication for the treatment of both symptomatic and asymptomatic ischemic episodes, as could be demonstrated in patients with coronary heart disease ascertained by angiography, positive exercise testing, and more than five ischemic episodes in Holter monitoring over 48 h." | 5.06 | [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias]. ( Barbato, G; Klein, H; Lichtlen, PR, 1989) |
| "In 12 male patients with angiographically confirmed coronary heart disease and stable angina the antianginal effects of 50 mg Gallopamil have been studied in comparison with 10 mg Nifedipine and placebo." | 5.05 | [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. ( Drews, H; Hopf, R; Kaltenbach, M, 1984) |
| "Efficacy and tolerance of gallopamil (Procorum) were investigated over a period of 1 year under practice conditions in a total of 455 patients (254 male, 201 female), aged 62 years (male) and 66 (female) on an average, with electrocardiographically confirmed coronary heart disease." | 3.67 | [Multicenter long-term study of gallopamil in patients with coronary heart disease]. ( Schiemann, J; Sućić, M, 1984) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 3.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "In intact rats, as well as in isolated perfused rat hearts, the calcium antagonist gallopamil reduced the severity of ischemic and reperfusion-induced arrhythmias." | 3.67 | The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion. ( Bernauer, W, 1987) |
| "Tedisamil is a new bradycardic agent proven to exert anti-ischemic and antiarrhythmic effects by blockade of the different cardiac and vascular K+ currents." | 2.69 | Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease. ( Haberbosch, W; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J, 1998) |
| "Tedisamil is a new bradycardic agent proven to exert antiischemic and antiarrhythmic effects by blockade of the cellular cardiac repolarization K+ currents as well as of multiple neuronal and vascular K+ currents (Ito, Ik, and K+ATP)." | 2.69 | Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists. ( Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J, 2000) |
| " Twenty-four-hour Holter monitoring, exercise testing, and adverse effects were controlled at days 7, 14, and 21." | 2.67 | Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil. ( Hohnloser, S; Just, H; Kosscheck, U; Meinertz, T; Weiss, C; Zehender, M, 1992) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 2.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "Verapamil pretreatment produced a similarly selective dilatation of larger coronary arterioles and protected against the ischaemia-induced fall in capillary red cell content." | 2.38 | Calcium antagonists and myocardial microperfusion. ( Köbler, W; Möller, P; Neumann, FJ; Parekh, N; Steinhausen, M; Tillmanns, H; Waas, W; Zimmermann, R, 1991) |
| "Pretreatment with gallopamil protected the mitochondria against the ischemically induced changes in RCI, state 3 respiration." | 1.28 | Protective effects of gallopamil against ischemia and reperfusion damage. ( Agnoletti, G; Boraso, A; Cargnoni, A; Condorelli, E; De Giuli, F; Ferrari, R; Ghielmi, S; Pasini, E, 1989) |
| "Gallopamil was effective and well tolerated, even in patients with very depressed cardiac function." | 1.28 | Clinical and hemodynamic effects of long-term administration of gallopamil in patients with coronary artery disease and normal or impaired left ventricular function. ( Dondi, M; Franchi, R; Magnani, B; Maiello, L; Marchetti, G; Monetti, N; Tartagni, F, 1989) |
| "Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)." | 1.26 | Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (54.00) | 18.7374 |
| 1990's | 22 (44.00) | 18.2507 |
| 2000's | 1 (2.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Bogaert, A | 1 |
| De Schepper, J | 1 |
| Hopf, R | 3 |
| Drews, H | 1 |
| Kaltenbach, M | 3 |
| Sućić, M | 1 |
| Schiemann, J | 1 |
| Raschack, M | 2 |
| Engelmann, K | 1 |
| Mitrovic, V | 3 |
| Oehm, E | 3 |
| Minge, C | 1 |
| Thürmann, P | 1 |
| Schlepper, M | 2 |
| Simonelli, P | 1 |
| Papa, A | 1 |
| Macciocchi, B | 1 |
| Auriemma, F | 1 |
| Vetrano, A | 1 |
| Scaletta Romeo di Santillo, M | 1 |
| Ceriello, A | 1 |
| Thormann, J | 2 |
| Pitschner, H | 2 |
| Haberbosch, W | 1 |
| Hamm, C | 1 |
| El-Sherif, N | 1 |
| Lazzara, R | 1 |
| Bogoliubov, VM | 1 |
| Lyskova, MN | 1 |
| Gribkova, IN | 1 |
| Kruglova, ZG | 1 |
| Neumann, FJ | 5 |
| Ott, I | 1 |
| Richardt, G | 3 |
| Zimmermann, R | 6 |
| Tillmanns, H | 6 |
| Kübler, W | 4 |
| Rauch, B | 4 |
| Barth, R | 2 |
| Schömig, A | 2 |
| Zehender, M | 1 |
| Kosscheck, U | 1 |
| Hohnloser, S | 1 |
| Weiss, C | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Steinbeck, G | 1 |
| Iliceto, S | 1 |
| Caiati, C | 1 |
| Tota, F | 1 |
| Rizzon, P | 1 |
| Rettig, GF | 1 |
| Jakob, M | 1 |
| Koch, HP | 2 |
| Ulianova, KN | 1 |
| Surovov, IuA | 1 |
| Sedov, VP | 1 |
| Sidorenko, BA | 1 |
| Lazzeroni, E | 1 |
| Morozzi, L | 1 |
| Campana, M | 1 |
| Botti, G | 1 |
| van Amsterdam, FT | 1 |
| Punt, NC | 1 |
| Haas, M | 1 |
| Zaagsma, J | 1 |
| Parekh, N | 2 |
| Waas, W | 1 |
| Möller, P | 1 |
| Steinhausen, M | 2 |
| Köbler, W | 1 |
| Neumann, J | 1 |
| Kranzhöfer, R | 1 |
| Di Mario, C | 1 |
| Iavernaro, A | 1 |
| Cucchini, F | 1 |
| Terrosu, P | 1 |
| Ibba, GV | 1 |
| Pes, R | 1 |
| Contini, GM | 1 |
| Delpini, A | 1 |
| Franceschino, V | 1 |
| Fantoccoli, D | 1 |
| Magri, M | 1 |
| Kirchengast, M | 2 |
| Hergenröder, S | 1 |
| Carlon, R | 1 |
| Cappelletti, F | 1 |
| Ometto, R | 1 |
| Maiolino, P | 1 |
| Vincenzi, M | 1 |
| Faria, DB | 1 |
| Goncalves, FR | 1 |
| Maroko, PR | 1 |
| Dorigo, O | 1 |
| Tiefenbacher, C | 1 |
| Reiterer, W | 1 |
| Ferrari, R | 2 |
| Boraso, A | 1 |
| Condorelli, E | 1 |
| De Giuli, F | 1 |
| Pasini, E | 1 |
| Cargnoni, A | 1 |
| Agnoletti, G | 1 |
| Ghielmi, S | 1 |
| Rafflenbeul, W | 1 |
| Jost, S | 1 |
| Berger, C | 1 |
| Lichtlen, P | 1 |
| Zebe, H | 1 |
| Sthler-Klich, HM | 1 |
| Steinbeck, C | 1 |
| Reuschel-Janetschek, E | 1 |
| von Arnim, T | 1 |
| Fleischer, K | 1 |
| Forster, A | 1 |
| Mohler, C | 1 |
| Schulz, PC | 1 |
| Kapp, M | 1 |
| Schlumpp, K | 1 |
| Bubeck, B | 1 |
| Georgi, P | 1 |
| Sinn, R | 1 |
| Wolf, R | 1 |
| Loskot, F | 1 |
| Novotny, P | 1 |
| Sucic, P | 1 |
| Schneider, G | 1 |
| Zenker, GD | 1 |
| Rödl, S | 1 |
| Genger, K | 1 |
| Barbato, G | 1 |
| Klein, H | 1 |
| Lichtlen, PR | 1 |
| Tartagni, F | 2 |
| Maiello, L | 2 |
| Marchetti, G | 2 |
| Dondi, M | 2 |
| Franchi, R | 2 |
| Monetti, N | 1 |
| Magnani, B | 2 |
| Gülker, H | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Bender, F | 1 |
| Eichstädt, H | 1 |
| Danne, O | 1 |
| Gutmann, M | 1 |
| Langer, M | 1 |
| Felix, R | 1 |
| Schmutzler, H | 1 |
| Stauch, M | 1 |
| Grossmann, G | 1 |
| Schmidt, A | 1 |
| Richter, P | 1 |
| Waitzinger, J | 1 |
| Wanjura, D | 1 |
| Adam, WE | 1 |
| König, W | 1 |
| Ceconi, C | 1 |
| Curello, S | 1 |
| Visioli, O | 1 |
| Bernauer, W | 1 |
4 reviews available for gallopamil and Coronary Disease
| Article | Year |
|---|---|
Calcium antagonists and silent myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Delayed-Action Preparations | 1992 |
The importance of stress-induced cardiac wall motion abnormalities in the evaluation of drug intervention.
Topics: Aged; Cardiac Pacing, Artificial; Coronary Disease; Echocardiography, Doppler; Female; Gallopamil; H | 1992 |
Calcium antagonists and myocardial microperfusion.
Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Gallopamil; Guinea Pigs; | 1991 |
[Procorum].
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Coronary Disease; Gallopamil; Humans | 1988 |
27 trials available for gallopamil and Coronary Disease
| Article | Year |
|---|---|
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1984 |
[Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Atrial Natriuretic Factor; Coronary Angiography; Cor | 1994 |
[The anti-ischemic effect of phosphodiesterase III inhibitors].
Topics: Administration, Oral; Calcium; Coronary Circulation; Coronary Disease; Cyclic AMP; Dose-Response Rel | 1994 |
[Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
Topics: Age Factors; Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Diltiazem; Drug Evaluati | 1993 |
Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Calcium Ch | 1998 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Age | 2000 |
Effect of gallopamil on neutrophil function: experimental and clinical studies.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Gallopamil; Humans; In Vitro Techniques; Neutrophi | 1992 |
Intracoronary gallopamil during percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Coronary Disease; Double-Blind Method; | 1992 |
Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
Topics: Aged; Arrhythmias, Cardiac; Circadian Rhythm; Coronary Disease; Electrocardiography; Electrocardiogr | 1992 |
Calcium antagonists and silent myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Delayed-Action Preparations | 1992 |
The importance of stress-induced cardiac wall motion abnormalities in the evaluation of drug intervention.
Topics: Aged; Cardiac Pacing, Artificial; Coronary Disease; Echocardiography, Doppler; Female; Gallopamil; H | 1992 |
[The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Dose-Response | 1992 |
Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiogr | 1992 |
Effect of gallopamil on myocardial ischaemia during percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Electrocardiography; Gallopamil; Huma | 1991 |
Exercise cardiovascular responses to gallopamil in ischemic heart disease.
Topics: Adult; Cardiac Catheterization; Coronary Disease; Diltiazem; Electrocardiography; Exercise; Exercise | 1991 |
[Gallopamil infusion for treatment of Prinzmetal angina].
Topics: Adult; Angina Pectoris, Variant; Coronary Disease; Electrocardiography, Ambulatory; Female; Gallopam | 1990 |
[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].
Topics: Angina Pectoris; Atenolol; Coronary Angiography; Coronary Circulation; Coronary Disease; Gallopamil; | 1989 |
[Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
Topics: Clinical Trials as Topic; Coronary Disease; Electrocardiography; Exercise Test; Female; Gallopamil; | 1989 |
[The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol].
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Dru | 1989 |
[Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Combined Modality Therapy | 1989 |
[Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Top | 1989 |
[Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Exercise Test; Fa | 1989 |
[Effect of 75 mg retard gallopamil on stress-induced myocardial ischemia].
Topics: Administration, Oral; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Electrocar | 1989 |
[Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Delayed- | 1989 |
[Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
Topics: Angina Pectoris; Coronary Angiography; Coronary Disease; Diltiazem; Electrocardiography; Exercise Te | 1989 |
[Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dela | 1989 |
[Procorum].
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Coronary Disease; Gallopamil; Humans | 1988 |
22 other studies available for gallopamil and Coronary Disease
| Article | Year |
|---|---|
Action of a calcium blocking agent (D600) on electrogenesis in the normal heart and the ischaemic heart in the dog.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Coronary Disease; Dogs; Electrocardiography; G | 1982 |
[Multicenter long-term study of gallopamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Female; Gallopa | 1984 |
Calcium antagonistic activity and myocardial ischemic protection by both stereoisomers of verapamil.
Topics: Animals; Aorta; Calcium; Coronary Disease; Dose-Response Relationship, Drug; Gallopamil; Heart; Rabb | 1983 |
Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Electrocardiography; Gallo | 1979 |
[Influence of anti-arrhythmia agents on electrolyte metabolism].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Female; Gallopamil; Humans; Hypertension; Mal | 1976 |
New experimental and clinical results on calcium antagonism. Proceedings of the 2nd International Gallopamil Symposium. Paris, November 8-9, 1991.
Topics: Animals; Coronary Disease; Gallopamil; Humans | 1992 |
[Significance of complex hemodynamic studies for the choice of therapy with the beta-adrenergic blocker, atenolol, and the calcium antagonist, procorum, in patients with ischemic heart disease].
Topics: Aged; Aged, 80 and over; Atenolol; Coronary Disease; Gallopamil; Hemodynamics; Humans; Middle Aged | 1992 |
Stereoisomers of calcium antagonists distinguish a myocardial and vascular mode of protection against cardiac ischemic injury.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cardiomyopathies; Coronary Circulation; Coronary Diseas | 1990 |
Acute effects of gallopamil on left ventricular systolic and diastolic function in patients with ischaemic heart disease.
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Diastole; Female | 1991 |
Reperfusion arrhythmias in closed-chest rats: the effect of myocardial noradrenaline depletion and Ca2(+)-antagonism.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Gallopamil; Heart Ventricles; Male; | 1991 |
Three-dimensional analysis of infarct size reduction after administration of gallopamil in dogs.
Topics: Animals; Autoradiography; Coronary Disease; Dogs; Female; Gallopamil; Hemodynamics; Male; Models, Bi | 1990 |
Pharmacologic effects on coronary microvessels during myocardial ischaemia.
Topics: Animals; Blood Flow Velocity; Capillary Permeability; Coronary Circulation; Coronary Disease; Corona | 1990 |
[Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Exercise Test; F | 1989 |
Protective effects of gallopamil against ischemia and reperfusion damage.
Topics: Adenosine Triphosphate; Animals; Calcium; Coronary Disease; Gallopamil; Male; Mitochondria, Heart; M | 1989 |
Effects of gallopamil, diltiazem and nifedipine on the loss of K+ from ischaemic pig hearts.
Topics: Animals; Coronary Disease; Diltiazem; Electrodes; Gallopamil; Heart; In Vitro Techniques; Male; Myoc | 1989 |
Clinical and hemodynamic effects of long-term administration of gallopamil in patients with coronary artery disease and normal or impaired left ventricular function.
Topics: Aged; Coronary Disease; Electrocardiography; Gallopamil; Heart; Heart Ventricles; Hemodynamics; Huma | 1989 |
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Dogs; Fem | 1987 |
Microperfusion in coronary artery disease under treatment with the calcium antagonist gallopamil.
Topics: Administration, Oral; Angina Pectoris; Coronary Circulation; Coronary Disease; Exercise Test; Female | 1988 |
Effect of gallopamil of left ventricular function in regions with and without ischaemia.
Topics: Coronary Disease; Female; Gallopamil; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Rad | 1987 |
[Comparative protective effect of gallopamil in myocardial ischemia and reperfusion].
Topics: Adenosine Triphosphate; Animals; Calcium; Catecholamines; Constriction; Coronary Disease; Coronary V | 1987 |
[Profile of the hemodynamic effect of gallopamil at rest and during exercise by angiocardio-scintigraphic studies: preliminary data].
Topics: Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Gallopamil; Heart; Hemodynamics; Human | 1987 |
The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Creat | 1987 |